[1] Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats

[2] Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants

[3] Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

[4] Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections

[5] Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly

[6] Clinical profile of serologically diagnosed pneumococcal pneumonia

[7] Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group